NCT00561002View on ClinicalTrials.gov

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

June 30, 2008

Conditions
Influenza
Interventions
BIOLOGICAL

2007-2008 Influenza Virus Vaccine

0.25 mL, Intramuscular

BIOLOGICAL

2007-2008 Influenza Virus Vaccine

0.25 mL, Intramuscular

Trial Locations (1)

Unknown

Norfolk

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00561002 - Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine | Biotech Hunter | Biotech Hunter